The human gut microbiome plays an important role both in health and disease. The use of antibiotics can alter gut microbiota composition, which can cause complications of various kinds. Here we report a whole genome sequencing metagenomic study of the intestinal microbiota changes caused by Helicobacter pylori eradication therapy. We have found the decrease in taxonomic alpha-diversity due to the therapy. The changes observed were more extensive for patients with duodenal ulcer and female ones. As well across the patients under the therapy we have detected the shifts in the metabolic potential and resistome. Seven KEGG pathways associated with quorum sensing, genetic Information processing and environmental Information processing were increased, while metabolic pathways related with metabolism of cofactors and vitamins and glycan biosynthesis and metabolism decreased. Changes in the resistome profile have also been identified.
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Introduction
Helicobacter pylori are ubiquitous bacteria classified by WHO as a cancer risk factor.
It has been estimated that up to 50% of human population harbor this pathogen. It is supposed that H. pylori colonized the human stomach about 60 000 years ago after humanity's ancestors migrated from Eastern Africa. Currently, H. pylori infection is associated with wide range of gastrointestinal diseases, including chronic gastritis, stomach ulcer, duodenal ulcer, gastric cancer, lymphoma of mucin-associated lymphoid tissue (Sanders et al., 2002 ). This bacterium is also responsible for irondeficiency anemia, Werlhof disease in children (Queiroz et al., 2013) , nutritional anemia due to vitamin B12 deficiency, thrombocytopenic purpura, lipid, and glucose metabolism disorders (Buzás, 2014) .
Conventional H. pylori eradication therapy regimens are based on antibiotics (clarithromycin, amoxicillin, tetracycline, metronidazole), proton pump inhibitors and some other auxiliary drugs treatment, including bismuth salts (Malfertheiner et al., 2017) . It is known that antibiotic treatment can significantly alter gut microbial community composition, and, as the result, may cause such complications as antibiotic-associated diarrhea (Bartlett et Thus, eradication therapy can have a great impact on the gut microbial community composition. These changes can drive gut disorders and cause accumulation of ARGs in the gut microbial community. Here we used whole genome shotgun sequencing (WGS) to study taxonomic and functional profile shifts of the gut microbial community in the patients after H. pylori eradication therapy. Our research may contribute to better understanding of the processes in the gut microbiota, which are driven by the complex mix of drugs used during H. pylori eradication therapy.
Results

Cohorts of patients and available data
In total, 80 gut metagenomic samples collected from 40 patients (47.7±13.11 years old, 18 female and 22 male) before and after the H. pylori eradication therapy lasting 14 days were examined. The samples obtained were divided into groups to perform statistical analysis. The first group included metagenomes collected prior to the eradication therapy (1st time point, 40 metagenomic samples). The second group included metagenomes from samples collected 0-2 days after the end of therapy 
H. pylori eradication therapy affects composition and richness of gut microbiota
As a result of taxonomic profiling with MetaPhlAn2, 51 genus and 106 species were detected in the patients' metagenomes. Eubacterium (15.46%±%13.45), Bacteroides (14.52%±16.92%) and Prevotella (14.43%±22.37%) were the most abundant genera at the 1st time point. The taxonomic composition of the 2nd point metagenomes was different: the most abundant genera included Bacteroides (22.77%±22.06%), Prevotella (14.06%±23.34%), Eubacterium (10.01%±16.08%). An increased relative abundance of Escherichia and Enterococcus was found after the therapy in the samples collected from four patients. Tables of taxonomic abundances at the genera   and species levels are presented in additional materials (Supplementary Tables S2-S3 ). The GraPhlAn visualization of the patient's gut microbiota community for two time points is presented in the Supplementary Figure S2 . The differences in the taxonomic structure of the patient's intestinal microbiota at two time points according to LEfSe analysis are presented in Figure 1 .
We compared the alpha-diversity and the Shannon indices between the 1st and the 2nd time points. The alpha-diversity of the intestinal microbiota composition differed significantly between the metagenomes before and after the eradication therapy: for the observed species Mann-Whitney P=2.80×10 -5 , for Jensen-Shannon index P=0.01 (see Supplementary Figure S3 ). However, there was no clear evidence for difference between the metagenomes of the 1st and 2nd time points based on the taxonomic composition (ANOSIM of Bray-Curtis dissimilarity values, R=0.075, P=0.002, 10 000 permutations). Distribution of the patients' gut community structures compared to the healthy persons (Voigt et al., 2015) at two time points is shown in Figure 2 .
To visualize the scale of changes in the taxonomic profile, the change in the alpha-diversity (Shannon / Simpson index) and the Bray-Curtis distance between the metagenomes of each patient at the 1st and 2nd time points was plotted ( Figure 3 ).
We observed that some metagenomes of the experimental group have undergone moderate (below mean value), medium (above mean value) and severe (higher than mean+SD) changes, whereas the metagenomes of those individuals who didn't take therapy (Voigt et al., 2015) did not show severe changes in the taxonomic composition on days 7 and 60 and were in the moderate zone. There were statistically significant differences in Bray-Curtis distance between time points in the experimental and control samples: Mann-Whitney P = 2.43 × 10 Tables S6-S7 ).
To study human gut microbiota functional shift in more detail, we analysed three specific microbiota functions which may be associated with eradication therapy Supplementary Table S9 ). Changes in the abundance of the resistance genes to biocide/metals and virulence factors were not detected (mapping results are present in Supplementary Tables S10-S11).
H. pylori eradication therapy affects the distribution of intraspecies structures
To analyze microbiota composition in more detail, i.e. on the intraspecies structure level, we used ConStrains. To detect intraspecies structures, this approach uses SNPs patterns found in the set of universal genes (Luo et al., 2015) . Totally, 500 strains (which is the sum of unique strains for each patient) were detected in the experimental group at the 1st and 2nd time points. We identified 371 intraspecies structures (total sum of the unique strains for each healthy individual) that formed a control sample. Intraspecies structure composition before and after treatment have been compared. The data obtained is shown in Figure 4 . It was shown that gut microbiota intraspecies structures within the case group are biased to scatter more than those of the control group. Bray-Curtis distance scales between the two groups was found to be significant (Mann-Whitney P=0.01).
We have compared the relative abundance of each gut microbiota intraspecies structure within the case and control groups. Only structures with nonzero relative abundance in two time points were included into the analysis. In control group metagenomes sampled following 7 and 60 days after the 1st sample collection were analyzed separately. The data is presented in Supplementary Figure S8 . The analysis revealed that intraspecies structures relative abundance in the experimental group is more unstable than that of the control group. We observed several species which relative abundance was almost constant but strains distribution varied greatly The PanPhlAn was used to study the functional capacity of specific bacterial species using microbial community data. This strain-level metagenomic profiling tool aims to identify pangenomes of individual strains in metagenomic samples (Scholz et al., 2016) . We were able to extract specific genes content from metagenomes for the most abundant taxa in the experimental group. To perform the analysis, two taxa (E. rectale и F. prausnitzii) were selected and their gene compositions were compared at different time points. The changes on KEGG Orthology (KO) groups abundances for both F. prausnitzii and E. rectale strains were found (see Supplementary Tables S12   and S14) . For E. rectale, 212 KOs increased after antibiotics therapy, 17 -decreased; for F. prausnitzii 5 KO increased and 30 KO -decreased. We merged KO by KEGG pathways and counted the number of changing genes for each pathway (see Supplementary Tables S13 and S15 ).
It should be noted, the observed changes in the metabolic profile of E. rectale were more extensive (this may be due to a higher reads coverage in the metagenomes of this bacterium, which allowed to extract more representative gene content distributions). The genes associated with ko01110 (biosynthesis of secondary metabolites), ko01130 (biosynthesis of antibiotics), ko02040 (flagellar assembly), ko02010 (ABC transporters), ko02030 (bacterial chemotaxis), ko02020
(two-component system) were increased that could be useful for survival in changed environmental conditions. These species in control group don't showed significant changes (threshold adj. P < 0.01).
H. pylori eradication therapy affects strains distribution of
Enterococcus faecium within microbiota
Enterococcus spp. multiple antibiotics resistance is alarming for the world medical community as this bacterium is prevalent among clinically significant microorganisms. Enterococci may collect different mobile elements and spread antibiotic resistance factors to the broad spectrum of gram-positive and gramnegative bacteria, including the transfer of vancomycin resistance to methicillinresistant strains of Staphylococcus aureus (Lebreton et al., 2017) .
We managed to recover E. faecium at two time points from the stool samples of only two patients (HP003, HP010). Strains isolated after the therapy had increased resistance to antibiotics (see Supplementary Table S16) , and had higher numbers of ARGs to macrolide and tetracycline antibiotics (ermB, tetL, tetM genes) (Supplementary Figure S10A) . Interestingly, E. faecium strains isolated after the therapy (E. faecium of 2nd time point) from both patients were similar in the SNPs pattern, and differed from E. faecium strains isolated at the 1st time point (Supplementary Figure S10B) . Also, E. faecium of 2nd time point relative abundance in the metagenomes after the therapy has grown when compared to the 1st time point isolates (Supplementary Figure S10C and Supplementary Figure S10D For the HP010 patient, it was not possible to reconstruct the environment of the ermB gene for any time point due to low coverage.
Discussion
Changes in the microbial community structure caused by H. pylori eradication therapy have been the subject of study before. Yap et al. (2016) 
used 16S
sequencing technique to study microbiota in young adults after eradication treatment. The authors showed that 6 months following the treatment Firmicutes relative abundance decreased, and Bacteroides abundance increased. However, the authors summarize that in general microbial community remains unchanged which may be due to the rather long time period that passed since the treatment compleet and compensatory processes that took place in the microbiota community.
Gut microbial community structure is altered by antibiotic treatment, which was shown both by the results described in this article and the data obtained by We determined statistically significant differences in microbiota functional profiles between the 1st and the 2nd time points. In general, the decline in seven KEGG pathways associated with cellular processes (ko02030, ko02024, ko02040), genetic Information processing (ko00970, ko03010) and environmental Information processing (ko02010, ko02020) were increased after eradication therapy.
Simultaneously, five KEGG metabolic pathways associated with metabolism of cofactors and vitamins (ko00130, ko00785) and glycan biosynthesis and metabolism (ko00511, ko00540) were decreased. The increasing pathways may be associated with better survival potential in the changed environment. Interestingly, we determined decline in ko01100 pathway (Metabolic pathways), this may be due to a overall impoverishment of the gut community.
We also detected prevalence of tetracycline ARGs in patients' microbiota before the therapy, which is consistent with previous findings (Hu et al., 2013) .
However, these genes decreased after therapy. Genes that determine resistance to macrolides (ermB, 23S rRNA methyltransferases group) were found to increase at the second time point. Similar results showing an increase of genes belonging to the 23S rRNA methyltransferases group were reported by Jakobsson et al. (2010) . It should be noted, the specific and non-specific mechanism of resistance to antibiotics were increased after eradication therapy.
Microbiota serves as ARGs reservoir and can transmit these genes to pathogenic bacteria. The decrease in relative abundance of the tetracycline resistance factors is of interest. This effect could be caused by the decline of the bacteria which possess these genes, as tetracycline is not included in the eradication therapy, and presence of the genes which determine resistance to this antibiotic doesn't give the critical advantage to their carriers under given circumstances.
Genes which determine resistance to biocide, heavy metals, and also virulence factors remained unchanged.
Interestingly enough, changes of the intraspecies structure distribution were more prominent in the experimental group compared to the control one. We 
Materials and methods
Sample collection
Faecal samples were acquired prior to and following eradication therapy from the patients suffering from diseases associated with H. pylori infectiongastroesophageal reflux disease (GERD), chronic gastritis, chronic duodenitis, and duodenal ulcer (see Supplementary Table S1 ). In all cases the H. pylori infection was confirmed by urease testing and cytological examination of mucosal biopsies collected from the antral part of the stomach during gastroscopy study. All patients included in the study received the H. pylori eradication treatment according to the Maastricht scheme (Malfertheiner et al., 2017) , which included amoxicillin 1000 mg, clarithromycin 500 mg, bismuth subsalicylate 240 mg, proton pump inhibitor (esomeprazole / pantoprazole) 20 mg. The therapy course lasted for 14 days.
Lactulose was used as a prebiotic throughout the therapy course. Before the start of the study, each patient signed an informed consent. Two sampling points were included: before the treatment and 0 or 2 days after the treatment. A total of 80 fecal samples from 40 patients were collected (47.7 ± 13.11 years old, 18 female and 22 male).
Sample preparation and sequencing
Stool samples were delivered to the laboratory and subsequently were stored at -20°C
. Before the DNA extraction procedure, the aggregate state of the samples was evaluated and their weight was determined. The weight of all the samples exceeded 20 grams, which was a sufficient quantity for the extraction of the required amount of DNA. Total DNA extraction was performed as described previously (Tyakht et 
Additional experimental data
The dataset from longitudinal study of gut metagenomes without intervention was used for the comparative data analysis and visualization (Voigt et al., 2015) . Also, we used previously published data from metagenome projects -ENA project ID faecium isolation and susceptibility testing are described in Supplementary Note 2.
Summary information on the samples used in the study is available in the Supplementary materials (Supplementary Tables S18-S20) .
Metagenomic sequences data preprocessing
The metagenomic reads were filtered by quality. Reads with an average quality value (QV) lower than 15 were discarded. To minimize sequencing errors, the remaining reads were processed with SAET software (Life Technologies) with parameters -qvupdate -trustprefix 25 -localrounds 3 -globalrounds 2. Further quality filtration was carried out as following: all positions starting from 5'-end were removed up to the 1st high quality position (QV ≥ 30). After filtering all the reads with the length less than 30 nucleotides were discarded. In order to remove fragments of human DNA from the data, the reads were mapped to the human genome (Homo sapiens hg38) using Bowtie (Langmead et al., 2009) with parameters -f -S -t -v 3 -k 1. If a read could be mapped in two or more places, the reference was chosen randomly and equiprobable. Reads unmapped to the human genome were converted from the color space to base space and used in further analysis.
Taxonomic and functional analysis of the metagenomes
Metagenomic taxonomic and metabolic profiling was performed using HUMAnN2 
Statistical analysis
The basic identification of differences at a taxonomic level was performed using linear discriminant analysis effect size (LEfSe) (Segata et al., 2011 ). The differences between community structures were evaluated using the Bray-Curtis metric. For additional analysis of the metagenomic composition, the MetaFast algorithm based on the adaptive assembly of de novo metagenomic reads was used. This algorithm evaluates the differences in metagenomes without the use of taxonomic annotation methods (Ulyantsev et al., 2016) . The ADONIS with the Bray-Curtis dissimilarity metric was used to identify the factors affecting the patients microbiota taxonomic composition (Oksanen et al., 2015) . Factors included gender, age, duodenal ulcer, chronic duodenitis, chronic gastritis, GERD and time point. The factors which significantly (threshold P<0.1) influenced the microbiota taxonomic composition were added to the multivariate analysis MaAsLin (Morgan et. al., 2012) . Relative abundance of different species and genera were considered as dependent variables.
Analysis scheme was as follows:
relative abundance of genus/species~time point+duodenal ulcer+gender To determine the differences in relative abundance of KEGG metabolic pathways, ARGs, resistance genes to biocide / metals and virulence factors the following operation were performed: the differences in the representation profiles were determined using the paired Mann-Whitney test (significance threshold: adjusted P<0.01) then significant differences of features were identified using gene set analysis (GSA) from piano bioconductor package (Väremo et al., 2013) (parameters: gene set analysis using "reporter feature algorithm", significance assessment using "gene sampling", gene set significance threshold: adjusted P<0.05 (Dubinkina et al. 2017) . Differences in KO abundances of extraction pangenomes by PanPhlAn was performed using Fisher exact test with Benjamini-Hochberg correction for multiple testing (FDR) (significant threshold adj. P<0.01).
Paired Mann-Whitney test was used for the additional differential analysis.
Data visualization was performed using R (R core team, 2016) and GraPhlAn (Asnicar et al., 2015) . 
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